Downloads
Publicado
agosto 29, 2020

Como Citar

SOARES, Janaina; REINALDO, Amanda Márcia dos Santos; GOMES, Natália de Magalhães Ribeiro; SILVEIRA, Belisa Vieira; PILLON, Sandra Cristina; PEREIRA, Maria Odete. O consumo de substâncias psicoativas na pandemia de COVID-19. Em: ESPERIDIÃO, Elizabeth; SAIDEL, Maria Giovana Borges (org.). Enfermagem em saúde mental e COVID-19. Enfermagem e PandemiasBrasília, Brasil: Editora ABEn,2020. v. 4 p. 37–44. DOI: 10.51234/aben.20.e04.c05. Disponível em: https://editoraaben.emnuvens.com.br/editora/catalog/book/20/chapter/143. Acesso em: 7 jun. 2026.

O consumo de substâncias psicoativas na pandemia de COVID-19

Autores
Janaina Soares, Universidade Federal de Minas Gerais; Amanda Márcia dos Santos Reinaldo, Universidade Federal de Minas Gerais; Natália de Magalhães Ribeiro Gomes, Universidade Federal de Minas Gerais; Belisa Vieira Silveira, Universidade de São Paulo; Sandra Cristina Pillon, Universidade de São Paulo; Maria Odete Pereira, Universidade Federal de Minas Gerais
Sinopse

A COVID-19 é a doença causada pelo novo coronavírus (SARS-CoV-2), notificada inicialmente em Wuhan, província de Hubei, China, em dezembro de 2019, e evoluiu para uma pandemia que se disseminou rapidamente pelo mundo, inclusive no Brasil, gerando uma emergência sanitária global. Além dos impactos sobre a saúde pública, imensos desafios e possibilidades de transformações sociais vêm sendo colocados à prova para a população mundial.

Referências

Ahmed Z, Ahmed O, Aibaoa Z, Hanbina S, Siyuc L, Ahmad A. Epidemic of COVID-19 in China and associated Psychological Problems. Asian J Psychiatr. 2020;51:102092. doi.org/10.1016/j.ajp.2020.102092

Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020;368(6490):489-493. doi:10.1126/science.abb3221

Organização das Nações Unidas [ONU]. United Nations Policy Brief: Covid-19 and the need for action on mental health [Internet] 2020. [cited 2020 jul 15]. Disponível em: https://www.un.org/sites/un2.un.org/files/un_policy_brief-covid_and_mental_health_final.pdf

Greenberg N, Docherty M, Gnanapragasam S, Wessely S. Managing mental health challenges faced by healthcare workers during covid-19 pandemic. BMJ. 2020;368:m1211. doi.org/10.1136/bmj.m1211

World Health Organization. Alcohol and COVID-19: what you need to know [Internet]. Geneva: World Health Organization; 2020 [cited 2020 jul 15]. Available from: https://www.euro.who.int/__data/assets/pdf_file/0010/437608/Alcohol-andCOVID-19-what-you-need-to-know.pdf

Hefler M, Gartner CE. The tobacco industry in the time of COVID-19: time to shut it down? Tobacco Control 2020;29:245246. doi: 10.1097/CM9.0000000000000775.

Hopkinson NS, Rossi N, Moustafa JEL-S, Laverty AA, Quint JK, Freydin MB, et.al. Current tobacco smoking and risk from COVID-19: results from a population symptom app in over 2.4 million people. medRxiv 2020.05.18.20105288. doi.org/10.1101/2020.05.18.20105288

Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198. doi.org/10.1136/bmj.m1198

Cattaruzza MS, Zagà V, Gallus S, D’Argenio P, Gorini G. Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature. Acta Bio Med. 2020;91(2):106-12. doi.org/10.23750/abm.v91i2.9698

van Zyl-Smit RN, Richards G, Leone FT. Tobacco smoking and COVID-19 infection. Lancet Respir Med. 2020 Jul;8(7):664-665. doi: 10.1016/S2213-2600(20)30239-3.

Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tobacco Induced Diseases. 2020;18:20. doi:10.18332/tid/119324.

Patanavanich R, Glantz SA. Smoking is Associated with COVID-19 Progression: A Meta-Analysis. 2020; Nicotine & Tobacco Research, 2020;1(4). doi:10.1093/ntr/ntaa082.

Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, Wei S, Deng Y, Liu J, Liu HG, Yang M, Hu Y. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J. 2020;133(9):1032-1038. doi: 10.1097/CM9.0000000000000775.

Silva Andre Luiz Oliveira da, Moreira Josino Costa, Martins Stella Regina. COVID-19 e tabagismo: uma relação de risco. Cad. Saúde Pública. 2020; 36(5). doi.org/10.1590/0102-311x00072020.

Clay, JM. Parker.MO. Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? Lancet Public Health, 2020. doi.org/10.1016/ S2468-2667(20)30088-8

Rehnm J, Kilian C, Ferreira-Borges C, Jernigan D, Monteiro M, Parry CDH, Sanchez ZM, Manthey J. Alcohol use in times of the COVID 19: Implications for monitoring and policy. Drug and Alcohol Review. 2020; 39:301–304. doi:10.1111/dar.13074

Xiang Yu-Tao et al. The COVID-19 Outbreak and Psychiatric Hospitals in China: Managing Challenges Through Mental Health Service Reform. Int J Biol Sci. 2020; 15;16(10):1741-1744. doi: 10.7150/ijbs.45072.

Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020; 395:912–20. doi.org/10.1016/S0140-6736(20)30460-8

Ministério da Saúde (Brasil). Saúde mental e atenção psicossocial na COVID-19: um guia para gestores [internet]. Fiocruz; 2020. Available from: http://www.fiocruzbrasilia.fiocruz.br/wp-content/uploads/2020/04/Sa%c3%bade-Mental-eAten%c3%a7%c3%a3o-Psicossocial-na-Pandemia-Covid-19-recomenda%c3%a7%c3%b5es-para-gestores.pdf

Chevance A, Gourion D, Hoertel N, Llorca P-M, Thomas P, Bocher R, Moro M-R, Lapr´evote V, Benyamina A, Fossati P, Masson M, Leaune E, Leboyer M, Gaillard R. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review. L’Enc´ephale. 2020. doi.org/10.1016/j.encep.2020.04.005

Dunlop A, Lokuge B, Masters D, et al. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduct J. 2020; 17:26. doi.org/10.1186/s12954-020-00370-7